CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $540,000 | -6.7% | 231,800 | +13.8% | 0.00% | 0.0% |
| Q4 2017 | $579,000 | -0.7% | 203,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $583,000 | +15.9% | 203,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $503,000 | -12.8% | 203,700 | +27.4% | 0.00% | 0.0% |
| Q1 2017 | $577,000 | +1.9% | 159,900 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $566,000 | -12.4% | 159,900 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $646,000 | -8.0% | 159,900 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $702,000 | +20.4% | 159,900 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $583,000 | -71.4% | 159,900 | +23.0% | 0.00% | -80.0% |
| Q4 2015 | $2,038,000 | +48.8% | 130,000 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $1,370,000 | -51.5% | 130,000 | +16.1% | 0.00% | -42.9% |
| Q2 2015 | $2,825,000 | -8.8% | 112,000 | +0.8% | 0.01% | -12.5% |
| Q1 2015 | $3,096,000 | +72.4% | 111,100 | +12.9% | 0.01% | +14.3% |
| Q4 2014 | $1,796,000 | +44.3% | 98,400 | +2.4% | 0.01% | +40.0% |
| Q3 2014 | $1,245,000 | -22.0% | 96,100 | -1.7% | 0.01% | -16.7% |
| Q2 2014 | $1,596,000 | -1.2% | 97,800 | +7.0% | 0.01% | 0.0% |
| Q1 2014 | $1,615,000 | -12.3% | 91,400 | +20.1% | 0.01% | -14.3% |
| Q4 2013 | $1,842,000 | -26.5% | 76,100 | +7.6% | 0.01% | -30.0% |
| Q3 2013 | $2,505,000 | +115.8% | 70,700 | -5.0% | 0.01% | +100.0% |
| Q2 2013 | $1,161,000 | – | 74,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $24,302,000 | 100.00% |
| TSP Capital Management Group, LLC | 886,398 | $3,138,000 | 1.60% |
| Marcus Capital, LLC | 109,950 | $389,000 | 0.42% |
| RTW INVESTMENTS, LP | 239,662 | $848,000 | 0.32% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 6,195,855 | $21,933,000 | 0.31% |
| Benchmark Capital Advisors | 66,800 | $236,000 | 0.20% |
| Bellevue Group AG | 160,000 | $566,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 632,944 | $2,241,000 | 0.09% |
| PDT Partners, LLC | 369,300 | $1,307,000 | 0.09% |
| Vident Investment Advisory, LLC | 196,715 | $696,000 | 0.08% |